Business & Tech

Genentech to Add 200 Jobs With $153 Million Vacaville Expansion

Genentech announced plans for another massive expansion, adding hundreds of jobs, and becoming the largest biotech manufacturing facility in the world.

Genentech announced plan to invest more than $285 million for the expansion of its biologics manufacturing facilities in Vacaville and Oceanside, California.

The press release stated: 
“This investment and expansion will result in the addition of more than 250 new jobs at the Vacaville and Oceanside facilities over the next four years, bringing the total number of Genentech manufacturing jobs in California to close to 3,000,” said Ian Clark, Chief Executive Officer of Genentech.

The company currently employs approximately 10,000 people in the state.

When the expansion is complete, Genentech’s Vacaville facility will not only be the largest producer of biologic medicines for the Roche Group, but also the largest biotech manufacturing facility in the world.

These investments in Genentech’s biologics manufacturing network will enable the hiring of hundreds of skilled workers, ranging from technicians to scientists and engineers.

According to the Daily Democrat, $153 million will be dedicated to the Vacaville location, adding 200 jobs to the expanding manufacturing facility. Hiring will begin in late 2013, and is to include more than 100 skilled technicians, scientists, engineers and quality professionals by the end of 2014. 

“California has always had an impressive skilled workforce that has allowed Genentech to hire diverse and talented individuals in various disciplines,” Clark said. “In recent years California has made great strides toward improving the business environment for life sciences innovation and incentivizing manufacturing. We are committed to working with the state to continue this positive progress and make California an even better place to grow the industry.”

Genentech’s United States manufacturing network spans three locations in California – South San Francisco, Vacaville, and Oceanside – and Hillsboro, Oregon, producing medicines intended for the treatment of a wide range of diseases including cancer, rheumatoid arthritis, and asthma.


Get more local news delivered straight to your inbox. Sign up for free Patch newsletters and alerts.

We’ve removed the ability to reply as we work to make improvements. Learn more here

More from Dixon